The Pulse of ACC

CathSap 5, ACC In-Training Exam, Registry Data in Action… and more news from the ACC.

Preventing ASCVD in China

The ACC this month held its 5th ASCVD Prevention Webinar in China, reaching a record 13,000 clinicians from 1,600 locations across the country. The number of participants was four-times that of any of the previous webinars held in China.

Read More >>>

The ASCVD Prevention Webinar program started in 2016 as a two-year program featuring three online webinars per year and social media content to educate physicians on primary and secondary prevention of ASCVD. Due to the success in China, the program expanded in 2017 to include nine other countries: Mexico, Argentina, UAE, Egypt, Saudi Arabia, Russia, Indonesia, Malaysia and Vietnam.

<<< Return to top

Testing the Waters: ACC In-Training Exam

Performance on the ACC In-Training Exam (ITE) is strongly correlated with performance on the American Board of Internal Medicine’s (ABIM’s) Cardiovascular Disease Certification Examination, according to the results of an analysis published June 5 in the Journal of the American College of Cardiology.

Read More >>>

The results of the primary analysis showed that ACC ITE scores were significantly correlated with scores on the first attempt of the ABIM Cardiovascular Disease Certification Examination (correlation coefficient = 0.68). Further, higher scores on both the ACC ITE and the ABIM Internal Medicine Certification Examination predicted higher scores on the Cardiovascular Disease Certification Examination. The secondary analysis also confirmed that the change in ACC ITE scores from the first to third year was a strong indicator of the ABIM Cardiovascular Disease Certification Examination score.

"This [analysis] indicates that the ACC ITE is a valuable predictive tool, and the results should be taken seriously by both the trainee and the training program," say the authors. They add that "the ITE examination [should be used] in all years of training to identify knowledge gaps and provide program directors the opportunity to address these gaps early on so as to improve the likelihood of passing the ABIM Cardiovascular Disease Certification Examination."

<<< Return to top

CathSAP 5 is Now Available

CathSAP 5 — ACC’s brand new self-assessment program — is now available and has everything needed to perfect knowledge of interventional cardiology. With an organizational structure that aligns directly with the American Board of Internal Medicine exam blueprint, the self-assessment program is also a great study tool to prepare for the Boards.

Read More >>>

The educational content is available in an abundance of formats and users can learn by reading text, watching a full-length or condensed presentation, downloading slides or answering questions which are now all case-based. There’s also the flexibility to create custom quizzes, simulate Board exams to personalize learning, compare scores with peers and view a dashboard to judge progress. CathSAP 5 offers 128 Continuing Medical Education/ Maintenance of Certification credits — enough for licensing and certification requirements through June 2020. Stay tuned for the CathSAP 5 App which will launch later this month.

<<< Return to top

Registry Data in Action

The FDA recently approved expanding the use of Sapien 3 Transcatheter Heart Valve (THV) for patients with symptomatic heart disease due to failure of a previously placed bioprosthetic aortic or mitral valve whose risk of death or severe complications from repeat surgery is high or greater. The FDA originally approved the Sapien 3 THV for transcatheter aortic valve eplacement as an alternative option to surgical aortic valve replacement for patients with native aortic stenosis whose risk for death or severe complications from surgery is high or greater.

Read More >>>

In 2016, the FDA approved furthering the expansion to include patients who are at intermediate-surgical risk for death or complications. The Sapien 3 THV is the first THV device approved for replacement of failed bioprosthetic aortic or mitral valves. The FDA evaluated data from the STS/ACC TVT Registry, which collects clinical data on the safety and effectiveness of transcatheter valve replacement procedures performed in a real-world setting.

<<< Return to top

In Memoriam: Kay Blum, PhD, CRNP

Kay Blum, PhD, CRNP, who served in a leadership capacity on many different ACC and Cardiovascular Team councils and committees, recently passed away. Blum started her career as a military nurse in the Army Nurse Cadet Corps-Baylor University in 1969. She went on to serve as a first lieutenant in the active duty Army Corps until 1974. She also served as a captain in the Army Reserve until 1979.

Read More >>>

She obtained her PhD in nursing and was both a clinical nurse specialist and an acute care nurse practitioner. Blum was also a professor and maintained her nursing practice as well. She was a much sought-after speaker and was published over 30 times in different forms. Her contributions to the ACC are too numerous to list them all.

“Dr. Blum was a role model for future generations,” said Deborah S. Croy, DNP, RN, ANP-BC, AACC. “She was a tireless advocate for her profession, peers and her patients. Her loss will be felt not only in the ACC community but by her family, friends, coworkers and students.”

<<< Return to top

Cardiology Magazine Download
Click the cover image above to read the latest issue of Cardiology in e-pub format or click here to read it on the web!

Clinical Topics:

Keywords: New-SupportingContent


< Back to Listings